• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转谷氨酰胺酶介导的纳米抗体聚乙二醇化用于靶向纳米药物递送。

Transglutaminase mediated PEGylation of nanobodies for targeted nano-drug delivery.

作者信息

Wu Tiantian, Huang Hai, Sheng Yaping, Shi Hongdong, Min Yuanzeng, Liu Yangzhong

机构信息

CAS Key Laboratory of Soft Matter Chemistry, CAS High Magnetic Field Laboratory, Department of Chemistry, University of Science and Technology of China, Hefei, Anhui 230026, China.

出版信息

J Mater Chem B. 2018 Feb 21;6(7):1011-1017. doi: 10.1039/c7tb03132g. Epub 2018 Feb 6.

DOI:10.1039/c7tb03132g
PMID:32254288
Abstract

Targeted delivery of anticancer drugs that selectively accumulate in malignant cells could enhance drug efficacy and reduce side effects of conventional chemotherapy. In this work, we designed a single domain antibody (nanobody) based drug delivery system for targeted delivery of anticancer drugs. An anti-EGFR nanobody (Nb) was constructed with a C-tag and a Q-tag for site specific modifications under physiological conditions. The site specific PEGylation of the nanobody was achieved via a transglutaminase catalyzed reaction through the coupling of the Q-tag with PEG-NH. As a proof of concept, the PEGylated nanobody was tethered to HSA coated upconversion nanoparticles (UCNPs) through the C-tag, and an anticancer drug, doxorubicin (DOX), was loaded. Results showed that the Nb-conjugated drug delivery system exhibits superior specificity to the EGFR positive tumor cells. The drug delivery system is highly accumulated in the EGFR positive tumor cells (A431), whereas there was no detectable accumulation in the EGFR negative cells (MCF-7). Consequently, the drug loaded particles demonstrated significantly higher anti-proliferation to A431 cells than to MCF-7 cells. This work provides an effective approach for site-specific modification of nanobodies for the construction of targeted drug delivery systems.

摘要

能够选择性地在恶性细胞中积累的抗癌药物靶向递送系统,可提高药物疗效并降低传统化疗的副作用。在本研究中,我们设计了一种基于单域抗体(纳米抗体)的药物递送系统用于抗癌药物的靶向递送。构建了一种带有C标签和Q标签的抗表皮生长因子受体(EGFR)纳米抗体,以便在生理条件下进行位点特异性修饰。通过转谷氨酰胺酶催化反应,使纳米抗体通过Q标签与聚乙二醇-氨基(PEG-NH)偶联,实现纳米抗体的位点特异性聚乙二醇化。作为概念验证,通过C标签将聚乙二醇化纳米抗体连接到白蛋白包被的上转换纳米颗粒(UCNP)上,并负载抗癌药物阿霉素(DOX)。结果表明,纳米抗体偶联的药物递送系统对EGFR阳性肿瘤细胞具有卓越的特异性。该药物递送系统在EGFR阳性肿瘤细胞(A431)中高度积累,而在EGFR阴性细胞(MCF-7)中未检测到积累。因此,载药颗粒对A431细胞的抗增殖作用明显高于对MCF-7细胞的作用。这项工作为纳米抗体的位点特异性修饰以构建靶向药物递送系统提供了一种有效方法。

相似文献

1
Transglutaminase mediated PEGylation of nanobodies for targeted nano-drug delivery.转谷氨酰胺酶介导的纳米抗体聚乙二醇化用于靶向纳米药物递送。
J Mater Chem B. 2018 Feb 21;6(7):1011-1017. doi: 10.1039/c7tb03132g. Epub 2018 Feb 6.
2
Nanobody-Ferritin Conjugate for Targeted Photodynamic Therapy.纳米抗体-铁蛋白偶联物用于靶向光动力疗法。
Chemistry. 2020 Jun 10;26(33):7442-7450. doi: 10.1002/chem.202000075. Epub 2020 May 19.
3
Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.用于pH响应型靶向给药的载阿霉素磁性壳聚糖纳米粒的合成
Eur J Pharm Sci. 2014 Oct 1;62:243-50. doi: 10.1016/j.ejps.2014.05.021. Epub 2014 Jun 12.
4
Tumor targeting using anti-her2 immunoliposomes.使用抗HER2免疫脂质体进行肿瘤靶向
J Control Release. 2001 Jul 6;74(1-3):95-113. doi: 10.1016/s0168-3659(01)00315-7.
5
Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity.载阿霉素介孔硒的氧化还原响应性递药靶向 MCF-7 细胞并协同增强其抗肿瘤活性。
Acta Biomater. 2017 May;54:294-306. doi: 10.1016/j.actbio.2017.02.042. Epub 2017 Mar 4.
6
Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy.上转换纳米颗粒用于多功能靶向癌细胞成像和治疗的药物传递。
Biomaterials. 2011 Feb;32(4):1110-20. doi: 10.1016/j.biomaterials.2010.09.069. Epub 2010 Oct 20.
7
Chemo-Enzymatic Functionalization of Bovine Milk Exosomes with an EGFR Nanobody for Target-specific Drug Delivery.牛乳外泌体的化学-酶法功能化及其表皮生长因子受体纳米抗体用于靶向递药
Chembiochem. 2024 Nov 18;25(22):e202400512. doi: 10.1002/cbic.202400512. Epub 2024 Oct 24.
8
Synthesis and in vitro and in vivo evaluations of poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) magnetic nanoparticles containing doxorubicin as a potential targeted drug delivery system.聚乙二醇-嵌段-聚(4-乙烯基苯膦酸酯)载多柔比星磁性纳米粒子的合成及其体内外评价作为一种潜在的靶向药物传递系统。
Colloids Surf B Biointerfaces. 2014 Jun 1;118:140-7. doi: 10.1016/j.colsurfb.2014.03.025. Epub 2014 Apr 8.
9
A camelid nanobody against EGFR was easily obtained through refolding of inclusion body expressed in Escherichia coli.通过对在大肠杆菌中表达的包涵体进行重折叠,很容易获得一种针对表皮生长因子受体(EGFR)的骆驼科单域抗体。
Biotechnol Appl Biochem. 2017 Nov;64(6):895-901. doi: 10.1002/bab.1544. Epub 2017 Aug 29.
10
Nanobody-siRNA Conjugates for Targeted Delivery of siRNA to Cancer Cells.纳米抗体-siRNA 缀合物用于靶向递送至癌细胞的 siRNA。
Mol Pharm. 2021 Mar 1;18(3):1048-1060. doi: 10.1021/acs.molpharmaceut.0c01001. Epub 2021 Jan 14.

引用本文的文献

1
Trends in nanobody technology in industrialization.纳米抗体技术的工业化发展趋势。
Discov Nano. 2025 Feb 10;20(1):23. doi: 10.1186/s11671-025-04200-2.
2
Radioiodinated Nanobody immunoPET probe for in vivo detection of CD147 in pan-cancer.用于泛癌中CD147体内检测的放射性碘化纳米抗体免疫正电子发射断层显像探针
Eur J Nucl Med Mol Imaging. 2025 Mar;52(4):1406-1421. doi: 10.1007/s00259-024-06985-3. Epub 2024 Nov 16.
3
Enhancing Tumor Immunotherapy by Multivalent Anti-PD-L1 Nanobody Assembled via Ferritin Nanocage.通过基于铁蛋白纳米笼组装的多价抗 PD-L1 纳米抗体增强肿瘤免疫治疗。
Adv Sci (Weinh). 2024 May;11(20):e2308248. doi: 10.1002/advs.202308248. Epub 2024 Mar 16.
4
Transglutaminase in Foods and Biotechnology.食品与生物技术中的转谷氨酰胺酶。
Int J Mol Sci. 2023 Aug 3;24(15):12402. doi: 10.3390/ijms241512402.
5
Atomically dispersed Mn boosting photoelectrochemical SARS-CoV-2 spike protein immunosensing on carbon nitride.原子级分散的锰增强氮化碳上的光电化学SARS-CoV-2刺突蛋白免疫传感
J Environ Chem Eng. 2022 Dec;10(6):108697. doi: 10.1016/j.jece.2022.108697. Epub 2022 Oct 3.
6
Microbial transglutaminase nanoflowers as an alternative nanomedicine for breast cancer theranostics.微生物转谷氨酰胺酶纳米花作为乳腺癌诊疗的替代纳米药物
RSC Adv. 2021 Oct 26;11(55):34613-34630. doi: 10.1039/d1ra04513j. eCollection 2021 Oct 25.
7
Novel development strategies and challenges for anti-Her2 antibody-drug conjugates.抗Her2抗体药物偶联物的新型研发策略与挑战
Antib Ther. 2022 Jan 27;5(1):18-29. doi: 10.1093/abt/tbac001. eCollection 2022 Jan.
8
CPPs to the Test: Effects on Binding, Uptake and Biodistribution of a Tumor Targeting Nanobody.细胞穿透肽的测试:对肿瘤靶向纳米抗体的结合、摄取和生物分布的影响
Pharmaceuticals (Basel). 2021 Jun 23;14(7):602. doi: 10.3390/ph14070602.
9
Interaction standards for biophysics: anti-lysozyme nanobodies.生物物理学相互作用标准:抗溶菌酶纳米抗体。
Eur Biophys J. 2021 May;50(3-4):333-343. doi: 10.1007/s00249-021-01524-6. Epub 2021 Apr 11.
10
Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy.纳米抗体:一种对肿瘤治疗策略具有重大影响的小抗体。
Int J Nanomedicine. 2021 Mar 22;16:2337-2356. doi: 10.2147/IJN.S297631. eCollection 2021.